Riedler G F
Abteilung für Hämatologie, Kantonsspital Luzern.
Schweiz Med Wochenschr. 1996 Nov 9;126(45):1946-51.
TYPE AND SCREEN: (T + S) means: no routine cross match before transfusion. ABO- and Rh-(Blgr) blood groups (type) are done and irregular allo-antibodies are sought (screen). If screen is negative, instant saline test (IST) or Blgr control, and if screen is positive, conventional cross match is done.
Are all clinically relevant antibodies discovered with T + S? Are laboratory costs lower?
Prospective study over more than 3 years. Blgr and cross match were done in tubes and AB screen and antibody identification (panel) were sought using the gel-test (DiaMed) with bromelin (enz) and LISS antiglobulin test (IAT). Underlying all testing were the directives of the Swiss blood donation services.
Enzyme-only positive antibodies are not relevant for blood transfusion, as shown by our data from more than 10000 comparisons of enz- and IAT-screens. 32 patients with positive enz-antibodies and negative cross match were transfused without problems. The enz-screen was abandoned for more than 12 months' follow-up in more than 20000 transfused patients. Before using the T + S, one unit of transfused RBC needed (on average) 3.7 cross matches, and after introduction of T + S only 0.3. Although the number of T + S increased significantly, we effectively saved some CHF 280000 per year.
血型鉴定与筛查(T + S)的含义为:输血前不进行常规交叉配血。进行ABO和Rh(D抗原)血型鉴定(血型检测)并筛查不规则同种抗体(筛查)。若筛查结果为阴性,则进行即时盐水试验(IST)或D抗原对照试验;若筛查结果为阳性,则进行常规交叉配血。
T + S能否发现所有临床相关抗体?实验室成本是否降低?
一项为期三年多的前瞻性研究。血型鉴定和交叉配血在试管中进行,AB筛查和抗体鉴定(谱细胞)采用含菠萝蛋白酶(酶)的凝胶试验(DiaMed)和低离子强度盐溶液抗球蛋白试验(IAT)。所有检测均遵循瑞士献血服务的指导原则。
仅酶法检测呈阳性的抗体与输血无关,我们对酶法和IAT筛查进行的10000多次比较数据表明了这一点。32例酶法抗体阳性且交叉配血阴性的患者输血时未出现问题。在超过20000例输血患者中,酶法筛查在超过12个月的随访中被放弃。在采用T + S之前,每输注一个单位的红细胞(平均)需要进行3.7次交叉配血,采用T + S后仅需0.3次。尽管T + S的数量显著增加,但我们每年有效地节省了约280000瑞士法郎。